During his appearance last month as the fifth annual Hounsfield memorial lecturer at the Imperial College London (England) Imaging Sciences Centre, MIT professor James Fujimoto said that screening and early stage diagnosis of cancers is a growth area for optical coherence tomography (OCT). Within days of Fujimoto's presentation, a number of announcements from commercial OCT developers addresses the use of the technology for cancer detection.
During his appearance as the fifth annual Hounsfield memorial lecturer at the Imperial College London (England) Imaging Sciences Centre, MIT professor James Fujimoto said that screening and early stage diagnosis of cancers is a growth area for optical coherence tomography (OCT).
Within days of Fujimoto's presentation, Within days of Fujimoto's presentation, OCT developer Volcano (San Diego, CA) told Massachusetts business journal Mass High Tech that it hopes to branch into cancer diagnosis--and another announcement reported a novel cancer detection system based on optical demultiplexed (OD) optical coherence tomography (OCT).
Similarly, skin cancer detection is a potential application of Michelson Diagnostics' VivoSight system, just released for clinical use in Europe.
Monday, July 20, 2009
Subscribe to:
Posts (Atom)